Register for our free email digests:
Marketing (Health)
Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
ASA Clears RB Of Misleading UK Consumers In Two Nurofen Ads
Product Launches
Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Latest From Health & Launches
Health Marketing Round-Up: January 2019
Health And Wellness Product Weekly Trademark Review Jan. 8, 2019
Trademarks registered and published for opposition with UDPTO in Class 3 – cosmetics and cleaning Preps, and Class 5 –pharmaceuticals. Marks for vitamin, mineral and supplement products also are registered or published for opposition in both Class 3 and Class 5.
Starpharma’s Innovative VivaGel Condom Ready For Launch in Japan
Advertising Campaigns
Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Latest From Health & Ad Campaigns
Gender Stereotypes in Ads Face Falling Foul Of New UK Regulations
Consumer health firms advertising in the UK - whether on television, online or through social media - will from June face tighter regulation aimed at protecting consumers from harmful gender stereotypes.
NiQuitin 'New Year, New You' Campaign Returns With Real-Life Quitter Testimonial
Advertising Enforcement
Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Latest From Health & Ad Complaints
Oral-B Enamel Repair Claim Has Second Brush With UK Advertising Authority
UK Advertising Standards Authority says despite P&G’s modification of a claim in TV ads for Oral B Gum and Enamel Repair toothpaste, visuals in the ad combined with claims suggest the product can repair enamel.
UK Nexium Ad Rapped For Downplaying Treatment For Persistent Heartburn
Pfizer’s TV ad for Nexium Control short-term heartburn treatment implied consumers with persistent heartburn need not seek professional medical advice, UK Advertising Standards Authority says. Pfizer argued that information in the ad was in line with MHRA's approval for the drug’s indications and packaging warned consumers not to use more than 14 days.
Bayer Slapped With Weighty Fine For Misleading Consumers in Hungary
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Article
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.